In vitro, synovial fibroblasts exposed to GSH reduced IL-6 secretion, suggesting a retreat of synovial inflammation [6]
The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners
Metal-based systems (MnO, Cu 2 , Fe 3 ) deplete GSH and generate ROS, with imaging potential, though metal toxicity and accumulation are concerns
This tells your body it must get fitter, stronger
You don't want your neurons to be that gooey, and yet you don't want them to be like concrete either